The Global COVID-19 Diagnostics Industry is positioned for exceptional growth, projecting a substantial climb to surpass the valuation of USD 204.51 billion by 2032, driven by an impressive compound annual growth rate (CAGR) of 7.7%. This anticipated surge reflects the crucial role of diagnostic tools in managing the ongoing pandemic. As global efforts continue to combat COVID-19, this market’s exponential expansion underscores the significance of accurate and efficient testing solutions. The trajectory not only demonstrates the resilience of the healthcare sector but also the industry’s commitment to advancing diagnostic technologies in the face of unprecedented challenges.
The report features unique and salient factors that may make a huge impact on the development of the Global Covid-19 Diagnostics Industry during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the years to come. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for a better understanding of readers.
The continuous efforts of established players, along with the springing up of local players, are providing increased competition in the COVID-19 diagnostics market. Local manufacturers are contributing to the rapid production of affordable and accessible testing solutions, especially in regions with high demand and limited resources. This has led to a more dynamic and competitive landscape, pushing for innovation and reducing costs across the board.
As the pandemic continues to evolve, diagnostic companies are focused on advancing technologies that ensure high accuracy, speed, and ease of use. These innovations are not only aimed at responding to the immediate COVID-19 crisis but also positioning the diagnostics market for future preparedness in handling pandemics. The ongoing efforts to enhance testing systems and improve the global testing infrastructure are pivotal in controlling the spread of COVID-19.
Key Takeaways:
- The COVID-19 diagnostics market is expanding with a focus on developing highly sensitive and specific testing kits.
- RT-PCR tests continue to dominate as the most widely used diagnostic tool for COVID-19 globally.
- The launch of automated testing systems by leading players is boosting production and improving testing efficiency.
- The rise of local players in various regions is intensifying competition and driving innovation in the diagnostics market.
Key Trends
- Development of Automated Testing Systems: Leading companies are enhancing production capabilities by launching automated COVID-19 testing systems, which streamline the testing process and improve efficiency.
- Emergence of Local Players: The rise of local diagnostic reagent and kit manufacturers is providing a competitive edge in the market, particularly in regions like Asia-Pacific, where rapid growth is expected due to high demand for testing solutions
- Government Initiatives: Significant government investments, such as the USD 600 million awarded by the U.S. government to accelerate diagnostics development, are boosting market growth
Major Players in the Covid-19 Diagnostics Market
The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.
Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.
Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.
The other major players include:
- Veredus Laboratories
- Thermo Fisher Scientific, Inc.
- Quidel Corporation
- Perkin Elmer, Inc.
- Neuberg Diagnostics
- Mylab Discovery Solutions Pvt Ltd.
- Luminex Corporation
- Laboratory Corporation of America Holdings
- Hologic Inc.
- Danaher
- Cepheid
- bioMérieux SA
- Altona Diagnostics GmbH
- ALDATU BIOSCIENCES
- ADT Biotech Sdn Bhd
- Abbott
- 1drop Inc.
Grab Your Complete Report Instantly
Key Segment
By Product Type:
- Instruments
- Test Kits
- Reagents and Consumables
By Sample Type:
- Oropharyngeal & Nasopharyngeal Swabs
- Blood
- Urine
- Others
By Technology:
- PCR
- ELISA
- POC
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube